Patent 7491402 was granted and assigned to Auckland Uniservices Limited on February, 2009 by the United States Patent and Trademark Office.
The invention provides superantigens SMEZ-2, SPE-G, SPE-H and SPE-J, as well as polynucleotides which encode them. Such superantigens have, inter alia, diagnostic and therapeutic application.